# A Clinical Study Evaluating Licaminlimab for Dry Eye Disease

> **NCT07548632** · PHASE2,PHASE3 · RECRUITING · sponsor: **Oculis** · enrollment: 160 (estimated)

## Conditions studied

- Dry Eye Disease (DED)

## Interventions

- **OTHER:** Artificial Tear Run-in
- **DRUG:** licaminlimab
- **OTHER:** Vehicle of licaminlimab

## Key facts

- **NCT ID:** NCT07548632
- **Lead sponsor:** Oculis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-16
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07548632

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07548632, "A Clinical Study Evaluating Licaminlimab for Dry Eye Disease". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07548632. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*